Hims & Hers Health Inc. has announced a new offer allowing eligible new customers to access a 6-month supply of Wegovy®, a prescription medication for obesity care, at a reduced price of $549 per month. This limited-time offer is part of the company's commitment to making obesity treatments more affordable and accessible to millions of Americans. The package includes access to Hims & Hers' holistic approach to weight loss, which incorporates technology-driven solutions and a variety of weight loss treatment options. CEO and co-founder Andrew Dudum emphasized the company's dedication to increasing access to essential health care services.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。